Krystal Biotech Quote, Financials, Valuation and Earnings

Krystal Biotech Price Quote

-6.43 (-3.92%)
(Updated: April 19, 2024 at 2:00 PM ET)

Krystal Biotech Key Stats

Krystal Biotech (KRYS) is a Sell

Day range:
$163.45 - $171.46
52-week range:
$82.09 - $189.97
Dividend yield:
P/E ratio:
P/S ratio:
P/B ratio:

Avg. volume:
1-year change:
Market cap:

How Much Does Krystal Biotech Make?

Data Unavailable

Is Krystal Biotech Growing As A Company?

Data Unavailable

Krystal Biotech Stock Price Performance

  • Did Krystal Biotech Stock Go Up Last Month?
    Krystal Biotech share price went down by -2.58% last month
  • Did KRYS's Share Price Rise Over The Last Year?
    KRYS share price rose by 84.48% over the past 1 year

What Is Krystal Biotech 52-Week High & Low?

Krystal Biotech Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Krystal Biotech?

  • How Much Debt Does Krystal Biotech Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Krystal Biotech Have?
    Cash and short term investments quarterly total is $532.2M
  • What Is Krystal Biotech’s Book Value Per Share?
    Book value per share is 27.58

Is Krystal Biotech Cash Flow Positive?

  • What Is KRYS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$88.8M
  • What Is Krystal Biotech’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $202.8M
  • What Is Krystal Biotech’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $82.6M

Krystal Biotech Return On Invested Capital

Data Unavailable

Krystal Biotech Earnings Date & Stock Price

Krystal Biotech Competitors

  • Who Are Krystal Biotech's Competitors?
    Below is a list of companies who compete with Krystal Biotech or are related in some way:
    • Alnylam Pharmaceuticals Inc (ALNY)
    • Axsome Therapeutics Inc (AXSM)
    • Catalyst Pharmaceuticals Inc (CPRX)
    • Ionis Pharmaceuticals Inc (IONS)
    • Madrigal Pharmaceuticals Inc (MDGL)

Krystal Biotech Dividend Yield

Data Unavailable

Krystal Biotech Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 479.17%
Revenue: 0% 40.82%

Analyst Recommendations

Buy Recommendations: 9
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 188.50
Upside from Last Price: 14.81%

Major Shareholders

  • How many KRYS shares are owned by institutional investors?
    42.2M KRYS shares are owned by institutional investors
  • How many KRYS shares are owned by insiders?
    3.5M KRYS shares are owned by insiders